Quantification of mitochondrial DNA mutation load by Greaves, Laura C et al.
Quantiﬁcation of mitochondrial DNA mutation load
Laura C. Greaves,
1 Nina E. Beadle,
1 Geoffrey A.
Taylor,
1 Daniel Commane,
2 John C. Mathers,
2
Konstantin Khrapko
3 and Doug M. Turnbull
1
1Mitochondrial Research Group, Institute for Ageing and Health,
Medical School, University of Newcastle upon Tyne, Framlington
Place, Newcastle upon Tyne, NE2 4HH, UK
2Human Nutrition Research Centre, Institute for Ageing and
Health, Newcastle University, Framlington Place, Newcastle upon
Tyne, NE2 4HH, UK
3Beth Israel Deaconess Medical Center, 330 Brookline Avenue,
Boston, MA 02215, USA
Summary
Mitochondrial DNA (mtDNA) mutations are an important
cause of genetic disease and have been proposed to play
a role in the ageing process. Quantiﬁcation of total
mtDNA mutation load in ageing tissues is difﬁcult as
mutational events are rare in a background of wild-type
molecules, and detection of individual mutated molecules
is beyond the sensitivity of most sequencing based tech-
niques. The methods currently most commonly used to
document the incidence of mtDNA point mutations in
ageing include post-PCR cloning, single-molecule PCR and
the random mutation capture assay. The mtDNA mutation
load obtained by these different techniques varies by
orders of magnitude, but direct comparison of the three
techniques on the same ageing human tissue has not
been performed. We assess the procedures and practicali-
ties involved in each of these three assays and discuss the
results obtained by investigation of mutation loads in
colonic mucosal biopsies from ten human subjects.
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Introduction
Mitochondrial DNA (mtDNA) is the only extrachromosomal
source of DNA in animal cells (Nass, 1966). In humans, it is a
16.6 kb double stranded molecule containing 13 protein
encoding genes which are all essential subunits of the mitochon-
drial oxidative phosphorylation system, as well as 22 tRNAs and
two rRNAs which enable mitochondria to synthesise some of
their own proteins (Anderson et al., 1981). Mutations in mtDNA,
both point mutations and large scale rearrangements, are an
important cause of genetic disease (Taylor & Turnbull, 2005),
and they have also been proposed to play a role in the ageing
process (Miquel et al., 1980).
Mitochondrial DNA mutations have been shown to accumu-
late with age in a number of postmitotic [e.g. brain (Cottrell
et al., 2001a), heart (Cortopassi & Arnheim, 1990), skeletal mus-
cle (Cooper et al., 1992)] and mitotic [colonic (Taylor et al.,
2003) and buccal epithelium (Nekhaeva et al., 2002)] human
tissues. These mutations have been shown to clonally expand to
a level, which causes respiratory chain deﬁciency. These respira-
tory chain deﬁcient cells can be detected using histochemical
techniques (Old & Johnson, 1989) and fractions of respiratory
chain deﬁcient cells calculated with ease. However, quantifying
the total mtDNA mutation load in ageing tissues is challenging
but of fundamental importance if we are to understand the
importance of mtDNA defects in human ageing.
A number of previous studies in human brain (Simon et al.,
2001) skeletal muscle (Del Bo et al., 2002) and blood (Wilding
et al., 2006), and numerous tissues in the mitochondrial mutator
mouse (Trifunovic et al., 2004; Kujoth et al., 2005) have
employed a post-PCR cloning strategy. This technique involves
DNA extraction followed by PCR ampliﬁcation of a target
sequence in the mitochondrial genome with a high-ﬁdelity DNA
polymerase. These PCR products are then cloned in a bacterial
vector, and the plasmid DNA re-ampliﬁed and sequenced. Each
individual PCR product is a copy of one mtDNA molecule and by
sequencing a large number of clones; the mutation load per
base pair can be quantiﬁed. This technique has come under criti-
cism recently as all DNA polymerase enzymes, including high
ﬁdelity enzymes, have an intrinsic error rate. Upon cloning, poly-
merase errors cannot be distinguished from true mutations and
may give an overestimation of mutation load. This can be con-
trolled for by ‘cloning a clone’ to calculate the polymerase error
rate, which can then be subtracted from the observed mutation
frequency. This will not, however, control for the artefactual ﬁx-
ation of base adducts into mutations, which is also thought to
occur with these enzymes (Kraytsberg et al., 2008). An alter-
native method is single-molecule PCR (Kraytsberg & Khrapko,
2005). This involves extraction of mtDNA from tissue sections
followed by serial dilution of the DNA down to a dilution in
which only one in every ﬁve PCR reactions contains an ampliﬁ-
able mtDNA molecule. This ensures that only one molecule is
being studied. This method allows any polymerase errors to be
identiﬁed. Indeed, any nascent PCR strand that acquires a poly-
merase error necessarily co-ampliﬁes with error-free fragments,
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land thus will appear on the electropherogram as a heteroplas-
mic peak and will be excluded from analysis. Single molecule
PCR (smPCR) may or may not exclude base adducts converted to
mutations, depending on DNA quality (Kraytsberg et al., 2008).
A third method has recently been developed, the random muta-
tion capture (RMC) assay (Vermulst et al., 2007). This assay
avoids the possibility of both polymerase errors and ﬁxation of
base adducts into mutations. The template DNA undergoes
restriction digestion prior to PCR, so that all molecules which are
wild-type at that restriction site will be cut and only molecules
with a mutation in that site remain intact. PCR primers which
ﬂank the restriction site are then used to amplify the mutant
molecules only. The starting template copy number is quantiﬁed
using real-time PCR, and the mutation frequency calculated as
the number of mutant bases per total number of base pairs
screened. In view of the importance of studying total mtDNA
point mutation load in ageing tissues, we have performed a sys-
tematic study to directly compare the three methods of quanti-
fying mutation load to determine if there are differences in the
results obtained with the different techniques. We also wished
to assess any difﬁculties there may be in the set up of the tech-
niques and their possible applications.
Results
Our ﬁrst objective was to assess the practicalities of setting up
and performing each technique. Post-PCR cloning is a simple
technique to establish as the whole process can be performed
using a commercially available kit and an advantage of the
post-PCR cloning technique is that it is able to be carried out
on small amounts of tissue or individual cells, not feasible with
the RMC assay. Single molecule PCR is also a relatively straight
forward technique to establish; however, time must be taken
to get the reaction conditions (primers, number of cycles,
cycling conditions) right, and extra care must be taken to avoid
cross-contamination. For a detailed review of these see Krayts-
berg et al., 2008 (Kraytsberg et al., 2008). One disadvantage
of this technique is the high dilutions of starting template
required; to investigate point mutations it is necessary to dilute
DNA so that only one in ﬁve wells contains an ampliﬁable tem-
plate (Kraytsberg et al., 2004). Therefore, to investigate high
numbers of bases a large number of PCR reactions are
required. In both techniques, post-cloning PCR and smPCR,
ampliﬁcation of nuclear pseudogenes is potentially possible as
long as total DNA, rather than puriﬁed mtDNA, is used for
analysis. Co-ampliﬁcation of pseudogenes occurs only with
certain combinations of PCR primers (Khrapko et al., 1994)
and it did not occur with the primers used in this work.
Sequences of all nuclear pseudogenes are known (Woischnik
& Moraes, 2002) and they are different from mtDNA in multi-
ple nucleotide positions and are readily identiﬁable if they do
co-amplify.
In our hands we found the RMC assay the most difﬁcult to
establish. The assay is extremely sensitive to primer sequence,
concentration and degradation and it was especially important
to check for ampliﬁcation of nuclear pseudogenes. To avoid
contamination we found it easier to amplify a larger product
using a standard PCR protocol rather than real-time PCR, this
meant that all products had to be electrophoresed following
PCR, rather than only those products which give a positive signal
on real-time PCR. There was also a problem with incomplete
digestion of the mtDNA sample prior to PCR. We were able to
overcome this by re-digesting the samples following PCR, then
running the samples on an agarose gel. We then excised only
the full length PCR products for sequencing. Figure 1 shows an
agarose gel image with a mixture of full length mutant bands
and wild-type bands, which have digested after PCR ampliﬁca-
tion. As a result of the changes in the protocol we wanted to
assess the sensitivity and speciﬁcity of the RMC assay in our
hands. To do this we cloned two PCR products in the region
5910–6396, one of which was wild-type at a Taq1a site within
that region (6014–6017), one of which had a T>C transition at
6014. The PCR products were cloned using the method
described above. Recombinant plasmids were identiﬁed and
plasmid DNA was prepared using a plasmid mini-prep kit (Qia-
gen Ltd, Crawley, UK). DNA was then further puriﬁed using phe-
nol⁄chloroform, ethanol precipitated, and resuspended in
dH2O. DNA concentration was quantiﬁed by UV absorption at
260 nm and copy number calculated. Both the mutant and wild
type clone were then diluted out so that each contained 1 · 10
6
molecules of target sequence. The mutant clone was then
diluted with the wild type clone in a ten-fold serial dilution from
10% mutant clone down to 0.00001% mutant clone. 1 lLo f
each dilution was then subjected to digestion with Taq1a for
10 h as described above in a total volume of 100 lL. This gave a
total copy number in each sample of 10 000 per lL. Each
dilution was then subjected to PCR as described above, the only
difference being the primers used were L5912-L5932 and
H6300-H6282. They were then re-digested and subjected to
electrophoresis. We found that in a background of 10 000 cop-
ies of wild-type DNA the RMC assay could reliably identify one
mutant molecule, and every PCR product that had been shown
to be resistant to digestion by Taq1a following PCR contained
1
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Fig. 1 Ethidium bromide stained agarose gel image following random
mutation capture analysis. Lanes 1 and 8: full length band following two
rounds of digestion, this band would be excised and gel extracted for
sequencing as it is presumed mutant. Lanes 3 and 9: PCR product which has
cut during the second round of digestion with Taq1a. This represents a
molecule which has not been digested during the ﬁrst restriction digest and
so has ampliﬁed during PCR. This shows the second round of digestion to be
necessary so as to identify only true mutants, and avoid unnecessary
sequencing. Lane 12: Control DNA from this subject which did not undergo
digestion prior to PCR, but does digest after PCR, which shows that this
subject does not have a polymorphic variant in the restriction site.
Quantiﬁcation of mitochondrial DNA mutation load, L. C. Greaves et al.
ª 2009 The Authors
Journal compilation ª Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland 2009
567the mutation within the Taq1a site. This showed that the RMC
assay was both highly speciﬁc and highly sensitive. In this study
we used a total of four different primer sets, one to quantitate
copy number (H12360 and L12464), a set for the actual experi-
ment (H6363 and L6851) and two different sets for the control
experiments (H5912 and L6300, and H14838 and L15437). To
check the efﬁciencies of the four primer sets, DNA from ﬁve dif-
ferent subjects was serially diluted from 1:10 to 1:10 000 and
standard curves generated for each primer set from each subject
using the real-time PCR conditions described in experimental
procedures. The mean slopes of the curves were; H12360 and
L12464:3.66 ± 0.08, H6363 and L6851:3.70 ± 016, H5912
and L6300:3.68 ± 0.09, and H14838 and L15437:3.67 ± 0.12.
There was no signiﬁcant difference in the primer efﬁciencies
(one way ANOVA, P = 0.88), therefore we were able to use them
to make quantitative measurements.
Investigation of mtDNA derived from human colonic mucosa
yielded average mutation loads of 2.3 · 10
)4 ± 1.0 · 10
)4 by
PCR⁄cloning, 5.9 · 10
)5 ± 3.2 · 10
)5 by single molecule PCR,
and 2.5 · 10
)6 ± 4.9 · 10
)6 for the RMC assay (mutation loads
for individual subjects are in Table 1 and Table 2 shows the num-
ber of bases investigated). The differences in mutation loads
were statistically signiﬁcant (Friedman test P<0.0001). Interest-
ingly none of the techniques showed any signiﬁcant trend with
age; however, this could be because of the small numbers of
subjects involved in this study (Fig. 2). In all the three experi-
ments the predominant type of mutation was a GA:CT transition
(Table 3, Fig. 3), followed by TC:AG transitions. Transversions
were quite rare except for GT:CA transversions by the RMC
method. However, there were no statistically signiﬁcant differ-
ences in the proportions of mutation types observed between
any of the methods employed in this study (ANOVA, P = 1.00).
Interestingly, the type of mutations observed here are very simi-
lar to those which we have previously shown to be clonally
expanded in cytochrome c oxidase deﬁcient crypts in human
colon (Taylor et al., 2003; Greaves et al., 2006). As a result of
the short target of investigation by the RMC method we went
on to look at a two additional Taq1a sites, 6014–6017 and
14596–14599, in the same 10 subjects as above and using an
identical protocol. The mean mutation load at the 6014–6017
site was 7.91 · 10
)6 ± 2.23 · 10
)5, and the mean mutation
load at the 14596–15499 site was 1.45 · 10
)6 ± 2.23 · 10
)6.
There was no signiﬁcant difference in the mutation loads
observed at the three sites (Friedman test P = 0.36). The types
Table 1 mtDNA mutation loads observed in
human colonic mucosa
Subject Age
Mutation load (mutations per base pair)
PCR ⁄Cloning
Single molecule
PCR RMC
1 45 2.5 · 10
)4 2.5 · 10
)5 0
2 46 4.1 · 10
)4 6.4 · 10
)5 7.7 · 10
)7
3 48 3.9 · 10
)4 7.5 · 10
)5 2.1 · 10
)6
4 52 1.5 · 10
)4 1.0 · 10
)4 6.9 · 10
)7
5 57 1.5 · 10
)4 7.6 · 10
)5 0
6 60 2.2 · 10
)4 1.0 · 10
)4 2.5 · 10
)6
7 64 2.2 · 10
)4 6.1 · 10
)5 0
8 72 2.3 · 10
)4 3.8 · 10
)5 2.0 · 10
)6
9 72 6.5 · 10
)5 0 5.8 · 10
)7
10 77 2.7 · 10
)4 5.1 · 10
)5 1.6 · 10
)5
Average ± SD 2.3 · 10
)4 ± 1.0 · 10
)4 5.9 · 10
)5 ± 3.2 · 10
)5 2.5 · 10
)6 ± 4.9 · 10
)6
Table 2 Number of bases investigated by each method
Subject
No. bases investigated
PCR ⁄
Cloning
Single
molecule PCR RMC
1 11 842 39 600 1 360 432
2 12 224 31 100 1 282 481
3 15 280 26 400 958 437
4 13 752 19 800 1 435 947
5 12 988 26 400 799 051
6 13 752 19 800 794 205
7 13 370 33 000 703 448
8 12 988 26 400 491 479
9 15 280 19 800 5 135 368
10 14 898 19 800 122 879
Fig. 2 mtDNA mutation load in human colon with age. Quantiﬁcation was
by post-PCR cloning (grey bars), single molecule PCR (SMPCR, checked bars)
and random mutation capture (RMC, black bars). Please note the logarithmic
scale used on the x-axis to make the all of the data visible.
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568of mutations observed at the three sites were also similar to
those previously seen.
Discussion
An important goal in ageing research is to determine the inci-
dence of mtDNA point mutations in ageing human tissues. To
this effect we wanted to study the potential value of the three
main methods currently available in colonic mucosa from 10
human subjects. There was a signiﬁcantly lower mutation load
detected by the RMC and single molecule PCR assays, than
post-PCR cloning. In addition, there was also a difference in
mutation load detected between the RMC assay and single mol-
ecule PCR. The differences between the three methods covered
two orders of magnitude. There are many possible causes for
these observed differences. PCR errors introduced during PCR
before cloning could artiﬁcially increase the mutation load.
There have been previous studies which have estimated the PCR
error rate using high ﬁdelity PCR enzymes. These estimates
range from 1.4 · 10
)5 (Smigrodzki et al., 2004) to 2.65 · 10
)5
(Wilding et al., 2006) mutations per base pair. These estimations
are comparable to or higher than the mutation loads we observe
with smPCR and RMC and may interfere withmutational analysis,
even when making comparative measurements. In addition to
this, analysis of mutation types is not possible with cloning as
there will be no way of differentiating between genuine and
artiﬁcial mutations. Neither smPCR nor RMC are affected by
these issues. A second potential source of artiﬁcially induced
mutation in both cloning and smPCR is ﬁxation of oxidative
and⁄or other chemical adducts on the mtDNA molecules into
mutations during PCR. Because of the restriction digest step
prior to PCR, the RMC assay is not affected by these issues.
One advantage of the cloning and the single molecule PCR
techniques is that the mutation load is calculated based on the
exact number of base pairs sequenced, which can be simply
counted; however, the RMC assay is reliant upon quantitation
of exact starting copy number prior to digestion with Taq1a,
which is dependent upon accurate quantiﬁcation of DNA con-
centrations. A second disadvantage of the RMC assay is the
short target of investigation; the short four base pair target of
the restriction enzyme may not accurately reﬂect the mutation
load across the whole genome. Indeed, there is evidence to sug-
gest that RMC may underestimate mutant fraction. We have
previously studied the incidence of clonally expanded mutations
in individual colonic crypts (Taylor et al., 2003; Greaves et al.,
2006). Estimates of clonal mutations are not subject to the vari-
ous artefacts that plague PCR-based methods (Kraytsberg et al.,
2007) and are free of the limitations of RMC. Crypt-by-crypt
analysis yielded an estimate of 2 · 10
)5 clonal mutations per
base pair in patients over 70 years of age (Taylor et al., 2003). If
we look only at the subjects over 70 years who were investi-
gated in this study, this is three times higher than the RMC esti-
mate and is approximately the same as the single molecule PCR
Table 3 Mutations observed in human colonic mucosa
Subject
Mutations detected
PCR ⁄ Cloning Single molecule PCR RMC
1 m.16172 T>C, m.16254 A>T, m.16399A>G m.14137C>T None
2 m.1607A>G, m.16192 C>A, m.16244G>A,
m.16327C>T, m.16111C>T
m.14182T>A, m.16060G>A 6564G>A
3 m.16069C>T, m.16126T>C, m.16174C>C,
m.16217T>C, m.16293C>G, m.16311T>C
m.12448T>C, m.12731T>C None
4 m.16216C>A, m.16389G>T m.13769-13787 Del, 15984T>C m.6565A>G
5 m.16125G>T, m.16223C>T m.368A>G, m.15246G>A m.6563C>T, m.6564G>T
6 m.16251C>T, m.16204G>A, m.16193 C ins,
m.16193 2C ins
m.14167C>T, m.14419C>T m.6363C>A,
m.6564-6566 Del
7 m.16071C>T, m.16265A>G, m.16394C>A m.13237 A Del, m.12301G>A None
8 m.16070A>G, m.16318A>G, m.16184C>T m.12991G>A m.6565A>G
9 m.16059A>T None m.6564G>A, m.6564G>T,
m.6562T>C
10 m.16071C>T, m.16104C>T, m.16114C>T,
m.16192C>T
m.103G>A m.6564G>A, m.6564G>A
Fig. 3 Types of mtDNA mutations observed in human colon. The types of
mutations detected by post-PCR cloning (grey bars), single molecule PCR
(SMPCR, checked bars) and random mutation capture (RMC, black bars) are
shown. The data are expressed as the percentage of the total number of
mutations observed by each technique.
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569estimate. Thefractionofclonally expanded mutationsrepresents
a lower estimate of total mutant fraction because in the tissue
there also may be an unknown proportion of nonexpanded
mutations, which are expected to be detected by all the three
methods compared here,but not bythe crypt-by-crypt analysis.
Interestingly, one possible reason for the lower estimates
obtained here by RMC as compared to crypt-by-crypt analysis,
may be that in our experiments RMC did not detect any signiﬁ-
cantly expanded point mutations of the kind that are detected
by the crypt-by-crypt analysis. The latter mutations constitute
about 80% of the mtDNA of a colonic crypt on average (Taylor
et al., 2003). As in this work there were 100–1000 crypts per
sample (depending on the biopsy size), the fraction of such a
clonally expanded mutation as quantiﬁed by RMC should be
2 · 10
)3–2 · 10
)4 [mutant fraction equals the fraction of
mutations in a mutant crypt (0.8) divided by the number of
crypts per sample (100–1000) and by the length of the target
sequence (4 bp)]. The most abundant RMC-detected mutation
frequency is at least 10 times less prominent than this (Table 1
sample 10), implying that the expansions detected by RMC are
no larger than the equivalent of 1⁄10 of a fully mutant crypt. Of
note, sample 10 (see Table 1) has a mutant fraction (as mea-
sured by RMC) at least 10-fold higher than that of all other sam-
ples, and this outlier is a major contributor to the apparent poor
reproducibility⁄precision of RMC. Most likely in sample 10 there
is a small (at most 1⁄10 of a fully mutant crypt) clonal expansion
of a mutation that by chance mapped within the RMC target.
This possibility is corroborated by the fact that both mutant mol-
ecules detected in this sample by RMC are identical, as expected
for a clonal expansion. The above argument implies that a repre-
sentative mutational assay based on RMC has to carefully con-
sider the sample size. At low sample size RMC is expected to
detect only nonexpanded mutations. At certain larger sample
size (depending on mutant fraction and the exact size distribu-
tion of clonal expansions) RMC starts detecting individual clonal
expansions, with resulting large variability between samples (this
is what is apparently observed in our experiments). At even
greater sample size, multiple clonal expansions will be detected
in each sample, and their contributions will average out to pro-
duce more stable estimates of the overall mutant fraction, which
now will include the share of clonal mutations. Note that the
other two methods where target sequence is much larger (i.e.
100-fold), the same stability of estimates is expected at
approximately 100-fold smaller sample size. In other words,
RMC is not an approach of choice for small samples with
expected clonal expansions.
There were no signiﬁcant differences in the types of mutations
observed in the three data sets, and they were all very similar to
the types of mutations which have been shown to clonally
expand to high levels in human colon (Taylor et al., 2003;
Greaves et al., 2006). This suggests that there is no selection for
particular mutations to clonally expand.
In conclusion we have shown that there is a very wide varia-
tion in mtDNA mutation load with a number of different tech-
niques. The RMC assay gives much lower mutation frequency
and although may not give a totally accurate estimate of muta-
tion load it is likely to be particularly useful for making compara-
tive measurements between a set of subjects (e.g. disease state,
dietary intake, genotype, age). Any errors in copy number,
potential mutational hotspots, or underestimation of mutational
load will be applicable to all subjects in the experiment. The
RMC assay is not affected by PCR errors, is high-throughput,
and is relatively cost-effective. However, because of the require-
ment of a mitochondrial preparation and a large sample size this
technique can only be used to look at homogenate tissues and
cannot be used to investigate individual cells or small pools of
the same cell type. Single molecule PCR, though less high
through-put, is free of PCR enzyme induced errors and may be a
better option for exact quantiﬁcation of mutation load, or to
look at very small amounts of tissue.
Experimental procedures
Subjects
Colonic mucosal samples were taken from subjects (n = 10, age
range 45–77 years) undergoing colonoscopy for a disturbance
of bowel function in whom no evidence of neoplasia or other
pathology was identiﬁed (BORICC 1 Study). Ethical approval was
obtained by the Joint Ethics Committee of Newcastle and North
Tyneside Health Authority and Northumbria NHS Trust Local
Research Ethics Committee.
Post-PCR cloning
To look at mutation load by PCR cloning, DNA was extracted
from sections of fresh-frozen colonic mucosa using a standard
lysis buffer (50 mM Tris–HCl pH 8.5, 1 mM EDTA, 0.5% Tween-
20, 200 ng mL
)1 proteinase K). 1 lL of DNA was used as tem-
plate to amplify a 442 bp fragment containing the HVS-1 region
of the mtDNA. PCR reactions comprised 30 pmol each of for-
ward (L15995-L16014) and reverse (H16401-H16382) primer
with 1 · PCR buffer (containing 2.0 mM magnesium sulphate),
200 lM dNTPs, 375 ng of DNA and 2.5 units of Pfu DNA poly-
merase (Stratagene, La Jolla, CA, USA). Ampliﬁcation was car-
ried out using a GeneAmp PCR System 9700 (Applied
Biosystems, Warrington, UK) under the following conditions:
94  C for 2 min followed by 30 cycles of 94  C for 1 min,
52  C for 1 min, 72  C for 1 min and a ﬁnal extension at 72  C
for 8 min. The PCR products were subjected to electrophoresis
on a 1.5% agarose gel and the DNA puriﬁed using a QIAquick
Gel Extraction Kit (Qiagen). A pCR-scriptTM Amp SK(+) cloning
Kit (Stratagene) was used to clone the products following the
manufacturer’s protocol. Recombinant plasmids were identiﬁed
by blue–white colour selection. White clones were re-plated on
ampicillin resistant plates and grown for 4 h. Colonies were
lysed in 40 lL of 10% Triton X-100 and 1.3 lL of the Triton
was then placed in a PCR reaction using the above PCR condi-
tions except using Ampitaq Gold DNA polymerase⁄buffer
(Applied Biosystems) and using a 10 min at 95  C starting
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570temperature. PCR products were cycle sequenced using ABI
BigDye chemistries per standard manufacturer’s protocols and
analysed on an ABI3100 genetic analyser (Applied Biosystems).
Sequences obtained were compared with the revised Cam-
bridge Reference Sequence (rCRS) and the homogenate
sequence for that patient, using SeqScape software (Applied
Biosystems). Mutation load was calculated for each patient by
dividing the number of mutant bases by the total number of
base pairs sequenced. In a control experiment we PCR ampliﬁed
and cloned a clone using exactly the same protocol as described
in above. Analysis of 100 clones of this clone did not reveal any
mutations. In a second control experiment we took DNA from
ﬁve of the subjects and ampliﬁed a region of the cytochrome b
gene, (primers used; L14797-L14816 and H15238-H15309) to
see if there were any differences in the mutation load between
the two areas. PCR, cloning and sequencing was carried out as
above. There was no signiﬁcant difference between the muta-
tion load found in the HVS-1 region to that found in the cyto-
chrome b region (t-test, P = 0.26, data not shown).
Single molecule PCR
To analyse mutation load by single molecule PCR whole sections
of colonic mucosa were lysed in 10 lL lysis buffer (10 mM EDTA,
0.5% SDS, 1% proteinase K) for 1 h at 37  C. The DNA was
then serially diluted in Tris–EDTA so that there was only one
ampliﬁable molecule in every ﬁve wells of a PCR plate to ensure
that we were looking at single molecules. Typically the optimal
concentration was 1⁄1 000 000. PCR was performed using
TaKaRa ExTak PCR system (Lonza Biologics plc, Wokingham,
UK) according to manufacturer’s recommended conditions
except that quadruple the volume of ExTak was used. After 40
cycles of ﬁrst round PCR (95  C for 20 s, 68  C for 7 min), 3 ll
of second round PCR mixture was added directly to the
ﬁrst round products and 25 further cycles of PCR carried out.
First round primers were L10161-L10192 and H780-H744;
second round primers were L10195-L10225 and H726-H694.
PCR products were subjected to electrophoresis in a 0.8%
agarose gel. All PCR products obtained were sequenced as
above. Mutation load was calculated by dividing the number of
mutant bases by the total number of base pairs sequenced.
Random mutation capture
To study mutation load using the RMC assay tissue homogeniza-
tion of the mucosal biopsy was carried out followed by differen-
tial centrifugation to obtain a crude mitochondrial pellet. Pellets
were incubated in a buffer containing proteinase K, and mtDNA
was subsequently extracted using phenol–chloroform followed
by ethanol precipitation and resuspension in dH2O. mtDNA was
then drop-dialysed using membrane ﬁlters (0.025 lm, Millipore
(UK)Ltd,Watford,UK)toextract anyexcesssalts.1 lLofmtDNA
was then digested with 100 U of Taq1a for 10 h with the addi-
tion of 100U every hour, giving a total volume of 100 lL. Abso-
lute quantiﬁcation of mtDNA copy number in the digested
mtDNA sample was carried out using SYBRGreen real-time PCR
on a Roche Lightcycler to a target template outside of a Taq1a
restriction sitebetweennucleotides 12360and 12464within the
ND5gene.Absolutequantitationwascarriedoutbythestandard
curve method. A template was generated between nucleotides
12284 and 13005. This was then puriﬁed using a gel extraction
kit (Qiagen) and quantiﬁed by UV absorption at 260 nm. It was
then serially diluted and used to generate a standard curve. All
measurements were made in triplicate. Having ascertained the
copynumberfor eachmtDNAsamplethe digestedsamples were
diluted to no more than 5000 target bases per lLi nd H 2O. A
Taq1a site within the gene for cytochrome c oxidase subunit 1
(6562–6565) was chosen for analysis. Each 25 lL PCR reaction
contained 12.5 pmoles each of forward and reverse primer pri-
mer (L6363-L6381 and H6851-H6831) with 1 · PCR buffer
(containing 2.0 mM magnesium sulphate), 200 lM dNTPs, and
1.25 U of Amplitaq Gold (Applied Biosystems). 1 lL of digested
mtDNA was added to each PCR reaction. A minimum of
100 000 base pairs were analysed per patient, and the number
of reactions carried out per patient was calculated depending on
the mtDNA copy number in that sample. PCR conditions were as
follows; 95  C for 10 min followed by 55 cycles of 95  C for
15 s, 57  C for 15 s and 72  C for 30 s, ﬁnal extension was at
72  C for 7 min. Following PCR each product was digested with
50 units of Taq1a for 1 h at 65  C, followed by 10 min at 80  C
to inactivate the enzyme. All products were then subjected to
electrophoresis on a 1.5% agarose gel for 1 h at 200 v. All full
length (488 bp) products were excisedfrom the gel andthe DNA
extracted using a gel extraction kit (Qiagen). These products
werethensequencedasdescribedabove.Mutationloadwascal-
culated by dividing the number of conﬁrmed mutants by the
totalnumberofbasepairsinvestigated.
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